General Information of Disease (ID: DISKFFSW)

Disease Name Muir-Torre syndrome
Synonyms
cutaneous sebaceous neoplasms and keratoacanthomas multiple with gastrointestinal and other carcinomas; cutaneous sebaceous neoplasms and keratoacanthomas, multiple, with gastrointestinal and Other carcinomas; MUIR-Torre syndrome; MRTES; Muir-Torre syndrome; multiple keratoacanthoma, Muir-Torre type
Definition
Muir-Torre syndrome (MTS) is a form of hereditary nonpolyposis colon cancer (HNPCC) characterized by cutaneous sebaceous tumors, keratoacanthomas and at least one visceral malignancy, most frequently gastrointestinal carcinoma.
Disease Hierarchy
DISPA49R: Hereditary nonpolyposis colon cancer
DIS3HIWD: Autosomal dominant disease
DISKFFSW: Muir-Torre syndrome
Disease Identifiers
MONDO ID
MONDO_0008018
UMLS CUI
C1321489
OMIM ID
158320
MedGen ID
231157
Orphanet ID
587
SNOMED CT ID
403824007

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 5 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
MRC1 TTKV8W5 Limited Genetic Variation [1]
MUTYH TTNB0ZK Limited Genetic Variation [2]
FHIT TTMS54D Strong Biomarker [3]
MLH1 TTISG27 Definitive Autosomal dominant [4]
MSH2 TTCAWRT Definitive Autosomal dominant [5]
------------------------------------------------------------------------------------
This Disease Is Related to 5 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
MYH1 OT8YBDOT Limited Genetic Variation [6]
MSH6 OT46FP09 Moderate Autosomal dominant [7]
PMS2 OTNLWTMI Moderate Autosomal recessive [7]
MLH1 OTG5XDD8 Definitive Autosomal dominant [4]
MSH2 OT10H1AB Definitive Autosomal dominant [5]
------------------------------------------------------------------------------------

References

1 Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome.Mol Genet Genomic Med. 2019 Jul;7(7):e00781. doi: 10.1002/mgg3.781. Epub 2019 Jun 4.
2 Biallelic MYH germline mutations as cause of Muir-Torre syndrome.Fam Cancer. 2010 Jun;9(2):151-4. doi: 10.1007/s10689-009-9309-x.
3 Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine.Proc Natl Acad Sci U S A. 2006 May 16;103(20):7823-8. doi: 10.1073/pnas.0601412103. Epub 2006 May 3.
4 Germline hMLH1 promoter mutation in a Newfoundland HNPCC kindred. Clin Genet. 2003 Sep;64(3):220-7. doi: 10.1034/j.1399-0004.2003.t01-1-00110.x.
5 A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening. J Med Genet. 1999 Oct;36(10):790-3. doi: 10.1136/jmg.36.10.792.
6 An individual with Muir-Torre syndrome found to have a pathogenic MSH6 gene mutation.Fam Cancer. 2007;6(3):317-21. doi: 10.1007/s10689-007-9119-y. Epub 2007 Feb 24.
7 The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.